ICD-10-CM Billable Code

D83.0

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

Clinical Classification Guidelines

Medical Intelligence & Overview

Common variable immunodeficiency (CVID), classified under ICD-10 code D83.0, is a disorder characterized by a weakened immune system. It primarily involves abnormalities in B-cell numbers and their ability to produce effective antibodies, leading to increased susceptibility to infections. CVID can develop at any age, but it is most frequently diagnosed in middle-aged adults. This condition can significantly impact quality of life due to recurrent infections and related complications, but with proper management, many individuals live active lives.

Causes & Symptoms

Clinical Causes: The exact cause of CVID remains unclear, but it is believed to involve genetic and environmental factors. Some cases are inherited, involving mutations in genes related to B-cell development and function. Others may result from immune regulation issues that are acquired over time. Unlike some immunodeficiencies caused by a single gene mutation, CVID typically exhibits a complex genetic basis with various involved genes, making its exact origins challenging to pinpoint in every patient.

Key Symptoms: Individuals with CVID may experience a range of symptoms, including: - Frequent respiratory tract infections such as sinusitis, pneumonia, or bronchitis - Recurrent gastrointestinal infections - Chronic diarrhea - Enlarged lymph nodes or spleen - Autoimmune disorders, such as anemia or rheumatoid arthritis - Increased susceptibility to certain types of cancers - Fatigue and general weakness - Skin infections or rashes The severity and frequency of symptoms can vary widely from person to person, often progressing gradually.

Diagnostic & Treatment

Diagnosis Path: Diagnosing CVID involves a combination of clinical assessment and laboratory tests. Healthcare providers typically consider the patient's medical history, especially the frequency and severity of infections. Confirmatory tests include: - Blood tests to measure immunoglobulin levels (commonly low IgG, IgA, and/or IgM) - Evaluation of B-cell numbers and function through flow cytometry - Assessment of vaccine responses to evaluate immune response capability - Exclusion of other causes of immunodeficiency or immune dysfunction A definitive diagnosis is generally made when immunoglobulin levels are persistently low, and other secondary causes have been ruled out.

Treatment Protocols: While there is currently no cure for CVID, treatment aims to reduce infections and manage associated complications. This typically involves: - Immunoglobulin replacement therapy: Intravenous or subcutaneous administration of pooled immunoglobulin helps boost the immune system's ability to fight infections. - Antibiotics: Used to treat and prevent bacterial infections. - Regular monitoring: To detect and address autoimmune manifestations or allergies early. - Management of associated conditions: Such as autoimmune disorders or gastrointestinal issues. - Lifestyle adjustments: Including proper hygiene, vaccination (as advised by healthcare providers), and avoiding exposure to infectious agents. Early diagnosis and consistent treatment are key factors in improving quality of life for individuals with CVID.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D83.0 a billable ICD-10 code?
Yes, D83.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D83.0?
Clinical documentation must specify the nature of Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

function immunodeficiency common variable abnormalities predominant numbers